Skip to main content

Milestone 5.A

Initiate first in human, phase I drug trials for therapeutic agents against at least 6 existing therapeutic targets. In addition to testing for safety, these trials will include assessment of target engagement.


Success Criteria

  • Completion of 12 Phase I drug trials for agents against 6 existing therapeutic targets.


Research Implementation Area
Drug Development - Existing Targets
Timeline
2017–2023
Status
In Progress

Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations